Mechanism of apoptosis induced by cisplatin and VP-16 in Panc-1 cells

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3445-3450

  Lee, Jeon Uk ^a   Hosotani, Ryo ^a   Wada, Michihiko ^a   Doi, Ryuichiro ^a   Kosiba, Takatomo ^a   Fujimoto, Koji ^a   Miyamoto, Yoshiharu ^a   Mori, Chisato ^a   Nakamura, Noriko ^a   Shiota, Kohei ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell line; Chemotherapy; Pancreatic cancer; TUNEL

Indexed keywords

CISPLATIN; ETOPOSIDE; MUTANT PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL ADHESION; CISPLATIN; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; GENES, P53; GROWTH INHIBITORS; HUMANS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0030830719     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ueda N and Shah SV: Apoptosis. J Lab Clin Med 124: 169-177,1994.
2. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska-M: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12(9): 3679-3684, 1993.
3. Cain K, Inayat-Hussain SH, Kokileva L and Cohen GM: Multi-step DNA cleavage in rat liver nuclei is inhibited by thiol reactive agents. FEBS-Lett 358(3): 255-261, 1995.
4. Cohen JJ and Richard CD: Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132: 38-42, 1984.
5. Kerr FR, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-rangin implications in tissue kinetics. Br J Cancer 26: 239-57, 1972.
6. Berger NA, Chatterjee S, Schmotzer JA and Helms SR: Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death. Proc Natl Acad Sci USA 88: 8740-8743, 1991.
7. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerated programmed cell death. Cell 74: 609-611, 1993.
8. Miyashita T, Harigai M, Hanada M and Reed JC: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135, 1994.
9. Miyashita T and Reed JC: Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell 80: 293-299, 1995.
10. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH: Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO-J 15(4): 827-838, 1996.
11. Lotem-J and Sachs-L: Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 10(6): 925-431, 1996.
12. Berrzpe G, Schaeffer J, Peinado MA, Real FX and Perucho M: Comparative analysis of mutation in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 58: 185-191, 1994.
13. Mori C, Nakamura N, Okamoto Y, Shiota K: Cytochemical identification of programmed cell death in the fusing fetal mouse palate by specific labelling of DNA fragmentation Anat Embryol 190: 21-28, 1 994.
14. Doi R, Wada M, Hosotani R, Lee JU, Koshiba T, Fujimoto K, Mori C, Nakamura N, Shiota K and Imamura M: Role of apoptosis in duct obstruction-induced pancreatic involution in the rats. Pancreas 14: 39-46, 1997.
15. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
16. Wada M, Doi R, Hosotani R, Lee JU, Koji F, Takatomo K, Miyamoto Y and Imamura M Expression of Bcl-2 and PCNA in ductal cells after pancreatic duct ligation in rats. Pancreas (in press).
17. Ormerod MG, O'Neill CF, Robertson D and Harrap KR: Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp Cell Res 211: 231-237, 1994.
18. Pergo P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC and Zunino F: Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell system. Cancer Res 56: 556-562, 1996.
19. Ludwig RL, Bates S and Vousden KH: Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol 16: 4952-4960, 1996.
20. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Man QX, Ordonez JV, Shroot B and Fontana JA: p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 443-504, 1995.
21. Kyriazis AP, Kyriazis AA, Yagoda A and Fogh J: Response of nude mouse-grown adenocarcinomas of the human exocrine pancreas to cis-diamminedichloroplatinum (II), diamine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride. Cancer Res 45: 4354-4359, 1985.
22. Hashimoto H, Chatterjee S and Berger NA: Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression. Cancer Res 55: 4029-4035, 1995.
23. Fan S, Smith ML, Rivet II DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ and O'Connor PM: Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55: 1644-1654, 1995.
24. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB and Roth J A Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54: 2287-2291, 1994.
25. Kotoh S, Naito S, Yokomizo A, Kumazawa J, Asakuno K, Kohno K and Kuwano M: Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Cancer Res 54: 3248-3252, 1994.
26. Nelson WG and Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53 dependent DNA damage response pathways. Mol Cell Biol 14: 1815-1823, 1994.